immunogenicity (Immune Epitope Database & Analysis Resource)
86
Structured Review
Immune Epitope Database & Analysis Resource
immunogenicity
Immunogenicity, supplied by Immune Epitope Database & Analysis Resource, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Databases/tool/pm39832278-192-15-8
Average 86 stars, based on 1 article reviews
Immunogenicity, supplied by Immune Epitope Database & Analysis Resource, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Databases/tool/pm39832278-192-15-8
Average 86 stars, based on 1 article reviews
immunogenicity - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Immunopeptidomics:Article Title: In Silico Design and Characterization of a Multi-Epitope Vaccine Candidate Against Mycoplasma pneumoniae Using a Reverse Vaccinology Strategy Article Snippet: .. The immunogenicity of MHC I peptides was predicted using the Class I Immunogenicity Article Title: Design of a multi-epitope vaccine against drug-resistant mycobacterium tuberculosis and mycobacterium bovis using reverse vaccinology. Article Snippet: .. We utilized the Immune Epitope Database (IEDB) Article Title: In Silico Design and Characterization of a Multi-Epitope Vaccine Candidate Against Mycoplasma pneumoniae Using a Reverse Vaccinology Strategy Article Snippet: .. The immunogenicity of MHC I peptides was predicted using the Class I Immunogenicity Article Title: Integrative immunoinformatics and molecular modeling approaches for the rational design and in silico validation of a multi-epitope vaccine candidate against human herpesvirus 7. Article Snippet: Human herpesvirus 7 (HHV-7) is a widespread β-herpesvirus associated with various clinical manifestations, particularly in immunocompromised individuals.. Despite its high prevalence, no licensed vaccine is currently available.. Advances in immunoinformatics and computational vaccinology provide efficient strategies for the rational design of targeted immunogens. Article Title: One Action and Multiple Results: Influenza A Virus and SARS-CoV-2 Poly-Epitope-Based Hybrid Vaccine Exploration by Reverse Vaccinology and Immunoinformatic Methods. Article Snippet: Introduction: Influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coinfection have been shown to intensify symptoms and, therefore, could be considered a significant threat to susceptible populations.. Although vaccination is an effective and safe strategy to be used against viruses, large amounts of mutations in these two viruses remain an issue for vaccine design, as some strains of the IAV and SARS-CoV-2 are still present worldwide, regardless of the introduction of various vaccines to protect against the Article Title: Computational Validation of Multi-Epitope mRNA Vaccine Targeting Streptococcus anginosus Surface Protein (TMPC) as an Effective Alternative Treatment to Reduce Gastric Cancer. Article Snippet: .. Finally, the immune epitope database (IEDB) Construct:Article Title: Computational Validation of Multi-Epitope mRNA Vaccine Targeting Streptococcus anginosus Surface Protein (TMPC) as an Effective Alternative Treatment to Reduce Gastric Cancer. Article Snippet: .. Finally, the immune epitope database (IEDB) Sequencing:Article Title: High-affinity recombinant antibodies enable a sensitive MRGPRX2-specific ELISA for detecting allergic rhinitis and chronic spontaneous urticaria. Article Snippet: Mas-related G-protein-coupled receptor X2 (MRGPRX2) plays a critical role in mast cell activation and the mediation of pseudo-allergic reactions, and its detection in peripheral blood is important for investigating mast cell–related disorders such as allergic rhinitis (AR), chronic spontaneous urticaria (CSU), and asthma.. However, existing assays based on polyclonal and hybridoma-derived monoclonal antibodies suffer from limitations in accuracy, reproducibility, and standardization, highlighting the need for alternative antibody strategies.. In this study, animals were immunized with a rationally selected MRGPRX2 peptide identified using the IEDB Analysis Resource, and sequence-defined recombinant monoclonal antibodies were generated. |